TEXAS A&M HEALTH SCIENCE CENTER

View full entity profile (contributions, contracts, SEC) →

Lobbying Spend

—

Filings

Firms Hired

Active Period

2021–2023

Lobbying Spend by Year

Client-reported lobbying expenses on LDA filings

Year	Lobbying Spend	Filings	Firms
2023	—	3	1
2022	—	4	1
2021	—	2	1

Hired Firms

Lobbying firms retained by this client; amounts are client-reported expenses when available

Firm Name	Reported Spend	Filings
TODD STRATEGY GROUP	—	9

Government Bodies Lobbied

Government entities explicitly identified as targets in LDA filings

Government Body	Filings
HOUSE OF REPRESENTATIVES	8
Health & Human Services, Dept of (HHS)	8
SENATE	8

Top Issues

Most frequently reported lobbying issues

Issue Code	Description	Reports
Health Issues	Health Issues	9

Bills Explicitly Cited (5)

Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded

H.R. 4369117th Congress

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

2022 · fourth_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

General education on Texas A&M Health Science Center. COVID-19 Response. H.R.4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021. Appropriations.

Client expense: — · Firm income: $40,000

Matched citations: H.R.4369

H.R. 4369117th Congress

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

2022 · third_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

General education on Texas A&M Health Science Center. COVID-19 Response. H.R.4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021. Appropriations

Client expense: — · Firm income: $40,000

Matched citations: H.R.4369

H.R. 4369117th Congress

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

2022 · second_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

General education on Texas A&M Health Science Center. COVID-19 Response. H.R.4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021. Appropriations.

Client expense: — · Firm income: $40,000

Matched citations: H.R.4369

H.R. 4369117th Congress

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

2022 · first_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

General education on Texas A&M Health Science Center. COVID-19 Response. H.R.4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021.

Client expense: — · Firm income: $40,000

Matched citations: H.R.4369

Show 1 more cited filings

H.R. 4369117th Congress

National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021

2021 · fourth_quarter · Firm: TODD STRATEGY GROUP

Open original LDA filing ↗

Cited source text and reported amounts

General education on Texas A&M Health Science Center. COVID-19 Response. H.R.4369: National Centers of Excellence in Advanced and Continuous Pharmaceutical Manufacturing Act of 2021.

Client expense: — · Firm income: $20,000

Matched citations: H.R.4369

Source: Senate LDA

TEXAS A&M HEALTH SCIENCE CENTER — Lobbying Disclosure | Poliscope